Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

479
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
479
Tumor Progression02:07

Tumor Progression

7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

463
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
463
Renal Corpuscle01:20

Renal Corpuscle

7.4K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
7.4K
Renal Clearance01:23

Renal Clearance

2.7K
The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
2.7K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

3.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of Clinical Features and Outcome of Leptospirosis associated AKI according to Acute Kidney Injury Net work Classification in a Tertiary Care Hospital of Bangladesh.

Mymensingh medical journal : MMJ·2025
Same author

Diagnostic accuracy of RISK6 assay in childhood pulmonary TB.

IJTLD open·2025
Same author

Detection of Helicobacter Pylori in Gastroduodenal Biopsy Samples of Dyspeptic Patients by Rapid Urease Test and Polymerase Chain Reaction in a Tertiary Care Hospital of Bangladesh.

Mymensingh medical journal : MMJ·2025
Same author

Relationship between Functional Dyspepsia and Gastric Eosinophilia: A Single Centre Cross-Sectional Study.

Mymensingh medical journal : MMJ·2025
Same author

Association of Helicobacter Pylori Infection with Functional Dyspepsia.

Mymensingh medical journal : MMJ·2024
Same author

A Rare Case of Partially Ossified Sacrospinous Ligament Causing Sciatic Nerve Compression.

Mymensingh medical journal : MMJ·2024

Related Experiment Video

Updated: Feb 1, 2026

Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure
06:46

Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure

Published on: December 22, 2023

1.2K

Renal failure and progressive pancytopenia.

J H Yeo1, A Islam2

  • 1Kings College Hospital, Denmark Hill, Brixton, London SE5 9RS, UK, jiehan.yeo@nhs.net.

The Journal of the Royal College of Physicians of Edinburgh
|November 30, 2018
PubMed
Summary

Secondary hyperparathyroidism can rarely cause myelofibrosis, a serious bone marrow condition. This case highlights the importance of considering this rare link in patients with kidney transplants and unexplained low blood counts.

Keywords:
myelofibrosispancytopeniarenal failuresecondary hyperparathyroidismtertiary hyperparathyroidism

More Related Videos

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression
06:29

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression

Published on: January 31, 2025

1.2K
Direct Drug Delivery to Kidney via the Renal Artery
11:18

Direct Drug Delivery to Kidney via the Renal Artery

Published on: April 17, 2021

8.2K

Related Experiment Videos

Last Updated: Feb 1, 2026

Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure
06:46

Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure

Published on: December 22, 2023

1.2K
Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression
06:29

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression

Published on: January 31, 2025

1.2K
Direct Drug Delivery to Kidney via the Renal Artery
11:18

Direct Drug Delivery to Kidney via the Renal Artery

Published on: April 17, 2021

8.2K

Area of Science:

  • Nephrology
  • Hematology
  • Endocrinology

Background:

  • Secondary hyperparathyroidism is a common complication in patients with chronic kidney disease and end-stage renal disease, often requiring management with vitamin D supplementation and phosphate binders.
  • Myelofibrosis is a rare bone marrow disorder characterized by the replacement of hematopoietic tissue with fibrous tissue, leading to pancytopenia.

Observation:

  • A 24-year-old female with a failed renal transplant and secondary hyperparathyroidism developed progressive pancytopenia despite standard treatments.
  • Her condition evolved to tertiary hyperparathyroidism, indicating a severe and persistent state of parathyroid overactivity.
  • A bone marrow biopsy was crucial in diagnosing myelofibrosis as the cause of her pancytopenia.

Findings:

  • The patient's pancytopenia was confirmed to be a direct result of myelofibrosis, strongly linked to her severe secondary hyperparathyroidism.
  • Successful parathyroidectomy led to the resolution of pancytopenia, underscoring the causal relationship between hyperparathyroidism and myelofibrosis in this case.

Implications:

  • This case underscores the rare but critical association between severe secondary hyperparathyroidism and myelofibrosis, particularly in renal transplant recipients.
  • It suggests that parathyroidectomy should be considered in managing refractory hyperparathyroidism complicated by hematological abnormalities like myelofibrosis.
  • Further research into the mechanisms linking hyperparathyroidism to myelofibrosis may reveal novel therapeutic targets.